United Therapeutics Corporation
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.97 | 3.03 | 7.58 | 4.89 | 7.79 | 7.01 | 9.49 | 3.97 | 11.88 | 7.23 | 9.82 | 6.85 | 36.79 | |
| 0.27 | 0.28 | 0.30 | 0.39 | 0.39 | 0.40 | 0.41 | 0.44 | 0.46 | 0.48 | 0.48 | 0.53 | 2.00 | |
| 0.42 | 0.33 | 0.52 | 1.05 | 0.86 | 0.55 | 0.65 | 0.78 | 0.83 | 0.81 | 0.72 | 1.69 | 4.13 | |
| 0.93 | -1.84 | 0.80 | -2.29 | 0.27 | -0.09 | 1.60 | -4.20 | 3.44 | -3.00 | 0.26 | -2.71 | -2.03 | |
| 1.32 | 1.58 | 0.77 | 0.95 | 1.58 | 1.78 | 1.54 | 1.29 | 4.45 | 3.61 | 2.14 | 2.36 | 12.93 | |
| -6.31 | 0.85 | 14.79 | -1.68 | -2.37 | -2.53 | -3.39 | -6.21 | 2.98 | -4.75 | 15.76 | 1.91 | 16.26 | |
| – | 0.15 | – | – | – | – | – | – | – | – | – | – | – | |
| 0.00 | 0.00 | -20.12 | -0.24 | -0.01 | -0.01 | -0.31 | -0.11 | -21.14 | 0.09 | -31.78 | -1.28 | -55.77 | |
| – | – | – | – | -2.07 | -2.05 | -2.06 | -4.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.15 | -1.86 | -21.49 | -1.01 | -1.32 | -1.53 | -1.93 | -4.11 | -20.21 | 2.05 | -31.45 | 2.67 | -48.46 | |
| 0.81 | 2.01 | 0.88 | 2.19 | 4.10 | 2.94 | 4.17 | -6.35 | -5.35 | 4.53 | -10.23 | 15.92 | 4.59 | |
| 5.64 | 1.45 | 6.81 | 3.94 | 6.21 | 5.23 | 7.95 | 2.68 | 7.43 | 3.62 | 7.68 | 4.49 | 23.86 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.